Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 3”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01783678
What this trial is testing

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

Who this might be right for
Chronic Hepatitis CHuman Immunodeficiency Virus
Gilead Sciences 275
Post-approval studies (Phase 4)Study completedNCT01429792
What this trial is testing

A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,013
Not applicableStudy completedNCT03341871
What this trial is testing

Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 1,095
Large-scale testing (Phase 3)Study completedNCT01846832
What this trial is testing

TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection

Who this might be right for
Hepatitis C, ChronicInfection
Janssen-Cilag International NV 232
Large-scale testing (Phase 3)Study completedNCT02170727
What this trial is testing

A Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 199
Large-scale testing (Phase 3)Study completedNCT01471574
What this trial is testing

Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus

Who this might be right for
Hepatitis C, Genotype 1
Bristol-Myers Squibb 549
Large-scale testing (Phase 3)Study completedNCT01581203
What this trial is testing

Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 748
Post-approval studies (Phase 4)Ended earlyNCT00641654
What this trial is testing

Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin

Who this might be right for
Chronic Hepatitis C
Göteborg University 75
Large-scale testing (Phase 3)Study completedNCT00538811
What this trial is testing

Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders

Who this might be right for
Hepatitis CGenotype 3Non-responders+1 more
Aga Khan University 40
Large-scale testing (Phase 3)Study completedNCT02442271
What this trial is testing

Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in Brazil

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 222
Testing effectiveness (Phase 2)Study completedNCT00561015
What this trial is testing

A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Tibotec BVBA 52
Large-scale testing (Phase 3)Study completedNCT02692703
What this trial is testing

Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2)

Who this might be right for
Chronic Hepatitis CHCVHepatitis C Virus
AbbVie 100
Large-scale testing (Phase 3)Study completedNCT00302081
What this trial is testing

Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 696
Post-approval studies (Phase 4)UnknownNCT00611819
What this trial is testing

Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV

Who this might be right for
Chronic Hepatitis CCo-Infection HIV-HCV
University of Valencia 59
Large-scale testing (Phase 3)Study completedNCT01585584
What this trial is testing

Triple-Therapy in Patients With HCV Genotype 3 Who Previously Failed Treatment

Who this might be right for
Hepatitis C
University of Calgary 11
Post-approval studies (Phase 4)Study completedNCT00143000
What this trial is testing

Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3

Who this might be right for
Hepatitis C Virus
NORDynamIC Study Group 392
Post-approval studies (Phase 4)Ended earlyNCT00255034
What this trial is testing

Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 146
Post-approval studies (Phase 4)Study completedNCT00830609
What this trial is testing

High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3

Who this might be right for
Chronic Hepatitis C
Dr. Conrado Fernandez 101
Testing effectiveness (Phase 2)Study completedNCT02133131
What this trial is testing

Efficacy and Safety of Grazoprevir (MK-5172), Elbasvir (MK-8742), and Sofosbuvir for Chronic Infection With Hepatitis C Virus Genotypes 1 and 3 (MK-5172-074)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 143
Large-scale testing (Phase 3)Study completedNCT02114177
What this trial is testing

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Janssen Infectious Diseases BVBA 310
Next Page